Importantly, a transfusion regimen reduces the HbS levels and increases total Hb [40] and hydroxyurea (HU) therapy [41] increases HbF levels and Hb concentration, which may lead to the prevention of first stroke in children with SCD. The gene discussed is GSTM1; the disease is Stroke.